Eli Lilly And Company (LLY) |
|
Eli Lilly Cash flow Statement Quarterly
LLY
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
Cash flow Statement (Quarterly, GAAP
in millions $) |
(Dec 31 2018) 12 Months |
(Sep 30 2018) 9 Months |
(Jun 30 2018) 6 Months |
(Mar 31 2018) 3 Months |
(Dec 31 2017) 12 Months |
Income |
3,232.00 |
2,107.00 |
957.50 |
1,217.40 |
-204.10 |
Depreciation & amortization |
1,609.00 |
1,263.50 |
848.00 |
422.80 |
1,567.30 |
Amortization of Other Assets |
- |
- |
- |
- |
- |
Write-down of identifiable intangibles
|
- |
- |
- |
- |
- |
Accountig change |
- |
- |
- |
- |
- |
In-process R & D |
- |
- |
- |
- |
- |
Increase (Decrease) in Inventories |
7.80 |
- |
- |
- |
-253.90 |
Minority Interests |
- |
- |
- |
- |
- |
Gain (Loss) on Disposition of Intangible Assets |
- |
- |
- |
- |
- |
Share-based Compensation |
279.50 |
206.70 |
138.20 |
68.00 |
281.30 |
Stockbased compensation |
- |
- |
- |
- |
- |
Gains (Losses) on Extinguishment of Debt |
- |
- |
- |
- |
- |
Acquired In Process Research And Development Net Of Tax |
- |
- |
- |
- |
- |
Research And Development Asset Acquired Other Than Through Business Combination Written Off |
-186.10 |
- |
- |
- |
- |
Income taxes |
346.70 |
320.70 |
183.10 |
21.00 |
3,931.10 |
Gain (Loss) on Investments |
- |
- |
- |
- |
- |
Increase (Decrease) in Accounts and Other Receivables |
-996.70 |
- |
- |
- |
-357.00 |
Increase (Decrease) in Accounts Payable and Accrued Liabilities |
-284.50 |
- |
- |
- |
916.30 |
Accrued expenses |
- |
- |
- |
- |
- |
Postretirement benefits |
- |
- |
- |
- |
- |
Increase (Decrease) in Deferred Income Taxes |
326.80 |
161.60 |
134.80 |
-22.70 |
-787.90 |
Other Working Capital |
-980.00 |
-1,638.20 |
-1,932.10 |
-1,270.00 |
-590.10 |
Other assets & liabilities |
- |
- |
- |
- |
- |
Other net |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Other Operating Activities |
- |
- |
- |
- |
0.00 |
Discontinued operations |
- |
- |
- |
- |
- |
Net Cash flow from
Operating Activities |
5,524.50 |
4,075.80 |
1,954.00 |
436.50 |
5,615.60 |
Capital Expenditures |
-1,210.60 |
-816.30 |
-546.50 |
-236.50 |
-1,076.80 |
Sale of Capital Items |
3.60 |
- |
- |
- |
40.70 |
Short-term Investments Proceeds |
-112.20 |
2,423.30 |
2,384.50 |
338.50 |
-3,389.70 |
Short-term investments acq. |
- |
- |
- |
- |
- |
Proceeds from other investments |
- |
- |
- |
- |
- |
Purchase Of In Process Research And Development |
- |
- |
- |
- |
- |
Purchased In Process Research And Development |
-386.00 |
- |
- |
- |
- |
Purchases Of In Process Research And Development |
- |
- |
- |
- |
- |
Increase (Decrease) in Restricted Cash |
- |
- |
- |
- |
- |
Noncontrolling interest |
- |
- |
- |
- |
- |
Proceeds from Investments |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Other Investments |
2,671.60 |
2,725.00 |
2,718.60 |
-251.10 |
-2,025.60 |
Purchases of Long-term assets |
- |
- |
- |
- |
- |
Acquisition Net of Cash Acquired |
-1,807.60 |
- |
- |
- |
-1,968.90 |
Investment in affiliate |
- |
- |
- |
- |
- |
Sale of businesses |
- |
- |
- |
- |
- |
Proceeds from sale of assets |
- |
- |
- |
- |
- |
Notes receivable |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Other Investing Activities |
-191.30 |
-188.80 |
-45.30 |
-21.20 |
-215.80 |
Other Net |
2,552.50 |
- |
0.00 |
- |
4,852.50 |
Discontinued operations |
- |
- |
- |
- |
- |
Net Cash flow from
Investing Activities |
1,906.00 |
2,565.00 |
2,963.10 |
-170.30 |
-3,783.60 |
Short-term debt Net |
-2,197.90 |
-2,297.10 |
-248.70 |
-1,202.50 |
1,397.50 |
Other borrowing transactions |
- |
- |
- |
- |
- |
Long-term debt - borrowings |
2,477.70 |
2,477.70 |
- |
- |
2,232.00 |
Long-term debt - repayments |
-1,009.10 |
-1,001.50 |
-1,001.50 |
-800.30 |
-630.60 |
Noncontrolling interest |
- |
- |
- |
- |
- |
Issuances/ -repurchases
of Comm. Stock |
-4,150.70 |
-3,050.70 |
-2,050.70 |
-1,100.00 |
-299.80 |
Exercise of stock options |
- |
- |
- |
- |
- |
Issuances/ -repurchases
of Pref. Stock |
- |
- |
- |
- |
- |
Discontinued Operations |
- |
- |
- |
- |
- |
Other financing activities net |
- |
- |
- |
- |
- |
Other net |
-372.80 |
-314.10 |
-230.40 |
-176.40 |
-364.40 |
Proceeds from Issuanceor Sale of Equity from Subsidiary |
- |
- |
- |
- |
- |
Dividends paid to minority interests |
- |
- |
- |
- |
- |
Dividends paid |
-2,311.80 |
-1,739.20 |
-1,166.60 |
-587.30 |
-2,192.10 |
Net Cash flow from
Financing Activities |
-5,904.90 |
-4,265.20 |
-4,697.90 |
-3,866.50 |
142.60 |
Effect of exchange rate on cash flow |
-63.60 |
48.20 |
61.90 |
148.40 |
-20.50 |
Discontinued operations |
- |
- |
- |
- |
- |
Free
Cash Flow |
4,317.50 |
3,259.50 |
1,407.50 |
200.00 |
4,579.50 |
Total Cash Flow |
1,462.00 |
2,423.80 |
281.10 |
-3,451.90 |
1,954.10 |
Cash & cash equiv. at beg.
of the Year |
6,536.20 |
6,536.20 |
6,536.20 |
6,536.20 |
4,582.10 |
Cash & cash equivalents at
end of period |
- |
- |
- |
- |
- |
Cash Interests paid |
- |
- |
- |
- |
- |
Cash Income taxes paid |
- |
- |
- |
- |
- |
|
|